Hybribio is one of the pioneering biotech companies specialising in in-vitro diagnostic products with a fully integrated one-stop operation chain from R&D, manufacturing, sales & marketing to after-sales technical support services. Furthermore, we are the sole company collaborating with the Ministry of Health of the People's Republic of China to establish the first HPV database system in China.

Currently, we provide products and services to over 6000 hospitals and medical institutes in China. Our diagnostic reagents have been exported to nearly 30 countries. The core patented technology of Hybribio obtained "the Gold Medal of China Patent Award" in 2016, and the competitive product of Hybribio's HPY diagnostic reagent has passed the external quality assessment of the World Health Organization for four consecutive years.

Working along with partners from different countries, our sales and marketing teams aim to provide an effective strategic marketing plan to suit different markets. Over 180 scientists and technical personnel stationed in mainland China and Hong Kong provide on-site technical training and after-sales technical service support. Hybribio's products have a high reputation around the globe, including European Region and African Region. Our products are widely recognized in foreign scientific research and medical institutions.